Order Article Reprints

Economopoulou P, Anastasiou M, Papaxoinis G, Spathas N, Spathis A, Oikonomopoulos N, Kotsantis I, Tsavaris O, Gkotzamanidou M, Gavrielatou N, et al. Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC). Cancers. 2021; 13(2):286. https://doi.org/10.3390/cancers13020286

Economopoulou, Panagiota, Maria Anastasiou, George Papaxoinis, Nikolaos Spathas, Aris Spathis, Nikolaos Oikonomopoulos, Ioannis Kotsantis, Onoufrios Tsavaris, Maria Gkotzamanidou, Niki Gavrielatou, and et al. 2021. "Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)" Cancers 13, no. 2: 286. https://doi.org/10.3390/cancers13020286

Economopoulou, P., Anastasiou, M., Papaxoinis, G., Spathas, N., Spathis, A., Oikonomopoulos, N., Kotsantis, I., Tsavaris, O., Gkotzamanidou, M., Gavrielatou, N., Vagia, E., Kyrodimos, E., Gagari, E., Giotakis, E., Delides, A., & Psyrri, A. (2021). Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC). Cancers, 13(2), 286. https://doi.org/10.3390/cancers13020286